Searched for
AMERICA MYLAN INC
Wall St boutique PJT Partners joins Indian M&A sweepstakes with PayU-BillDesk dealThe six-year-old firm had roped in former Citi India CEO Pramit Jhaveri as senior advisor to help grow base.- Culture of ‘bending rules’ in India challenges U.S. drug agencyThe US drug agency is bewildered with Indian pharma industry's culture of getting things done at all costs.
- need2know: 10 market-moving macro triggers to watch todayA lowdown on top macro triggers that may move market on Friday
- Market may be tentative, opportunities are not: 7 stock ideas to make moneyThe news on the monsoon front is good. The first wave of March quarter results shows early signs of earnings revival in some pockets of Ind...
- 2015 in review: Mergers and acquisitions peak in pharma industry; so does regulatory glareThe year also saw the government making an attempt to expand drugs under price control by revising the list of essential medicines.
- Mylan Inc to acquire Famy Care's certain business for $ 800 millionMumbai-based Famy Care is focused on female reproductive health care and is world leader in supplying a wide range of contraceptive pills.
- Mylan expands pact with Gilead for hepatitis-C drugDrugmaker Mylan Laboratories Ltd said it has expanded its hepatitis C licensing agreement with Gilead Sciences, a US-based biopharma compan...
- 29 people with 'soft' college majors who became extremely successfulHere are 29 extremely successful people who prove that it's possible to climb the ladder without a bachelor's degree in business or science.
- Natco Pharma's partner Mylan Inc files ANDA for generic CopaxoneAccording to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
- Megadeals drive torrid pace for M&A activity, hits $1 trillion in four monthsThe value of corporate takeovers announced in 2014 hit the $1 trillion mark Monday, reaching that level at the fastest pace in seven years.
- Ten stocks in focus in Friday morning tradeIndian markets are likely to trade in a range. Here is a list of ten stocks which are likely to be in focus in trade today.
- I admire Dilip Shanghvi of Sun Pharma, says Lupin’s Vinita GuptaNilesh and I complement each other and share a common passion when it comes to the company - Vinita Gupta
- Teva Pharmaceuticals will not be launching Atorvastatin, generic version of LipitorIsrael's Teva Pharmaceuticals will not launch atorvastatin, the generic version of Lipitor, that will help Indian cos Ranbaxy and Dr Reddy'...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- US election to benefit some industries, harm othersEnergy, pharmaceutical and telecommunications cos could face tax and other policy changes no matter who wins the White House. Profile: McCa...
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
Load More
